Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Buchanan

Showing results (81-90 of 298) with videos related to

Pageof 30
Sort By:
Future Oncology (London, England)|February 6, 2016
Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screeningMark A Jenkins, Enes Makalic, James G Dowty, et al.
Familial Cancer|January 5, 2013
Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?Mark Clendenning, Michael D Walsh, Judith Balmana Gelpi, et al.
Genes & Cancer|January 26, 2016
Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndromeAung Ko Win, Mark Clendenning, William Crawford, et al.
JAMA Oncology|June 19, 2015
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryMatthew B Yurgelun, Serena Masciari, Victoria A Joshi, et al.
Carcinogenesis|February 10, 2011
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patientsJames B Rawson, Michael Manno, Miralem Mrkonjic, et al.
Human Mutation|March 10, 2009
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold, Daniel D Buchanan, Melissa Barker, et al.
Gut|September 2, 2016
Lack of evidence for germline <i>RNF43</i> mutations in patients with serrated polyposis syndrome from a large multinational studyDaniel D Buchanan, Mark Clendenning, Li Zhuoer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 29, 2022
Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older IndividualsAndrew Bakshi, Yin Cao, Suzanne G Orchard, et al.
Epigenetics|June 21, 2022
Does genetic predisposition modify the effect of lifestyle-related factors on DNA methylation?Chenglong Yu, Allison M Hodge, Ee Ming Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal CancerJoice Kuroiwa-Trzmielina, Fan Wang, Robert W Rapkins, et al.
Pageof 30

Showing results (81-90 of 298) with videos related to

Sort By:
Pageof 30
Future Oncology (London, England)|February 6, 2016
Quantifying the utility of single nucleotide polymorphisms to guide colorectal cancer screeningMark A Jenkins, Enes Makalic, James G Dowty, et al.
Familial Cancer|January 5, 2013
Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?Mark Clendenning, Michael D Walsh, Judith Balmana Gelpi, et al.
Genes & Cancer|January 26, 2016
Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndromeAung Ko Win, Mark Clendenning, William Crawford, et al.
JAMA Oncology|June 19, 2015
Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family RegistryMatthew B Yurgelun, Serena Masciari, Victoria A Joshi, et al.
Carcinogenesis|February 10, 2011
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patientsJames B Rawson, Michael Manno, Miralem Mrkonjic, et al.
Human Mutation|March 10, 2009
Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristicsSven Arnold, Daniel D Buchanan, Melissa Barker, et al.
Gut|September 2, 2016
Lack of evidence for germline <i>RNF43</i> mutations in patients with serrated polyposis syndrome from a large multinational studyDaniel D Buchanan, Mark Clendenning, Li Zhuoer, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 29, 2022
Aspirin and the Risk of Colorectal Cancer According to Genetic Susceptibility among Older IndividualsAndrew Bakshi, Yin Cao, Suzanne G Orchard, et al.
Epigenetics|June 21, 2022
Does genetic predisposition modify the effect of lifestyle-related factors on DNA methylation?Chenglong Yu, Allison M Hodge, Ee Ming Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2016
SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal CancerJoice Kuroiwa-Trzmielina, Fan Wang, Robert W Rapkins, et al.
Pageof 30